Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders
Abstract Background Individuals with substance use disorders (SUDs) are at increased risk for hepatitis C viral infection (HCV), and few studies have explored their treatment responses empirically.The objective of this study was to assess interferon alpha therapy (IFN) completion and response rates among patients with HCV who had a history of comor